Modifying CAR T-cells to kill solid tumours
New company created to tackle paediatric cerebral palsy
Strategic partnership to advance space-based life sciences research infrastructure
HanchorBio receives FDA Orphan Drug Designation for gastric cancer drug
FDA Rare Pediatric Disease designation for mucopolysaccharidosis Type II treatment
CIRM approves $100m plan to accelerate genetic therapies for patients with rare diseases
Researchers develop more reliable platform to test antibody medicines
Positive topline results from acne study
Sarbecovirus vaccine trial starts
Vetter Pharma to build new manufacturing site in Germany
New dementia treatment strategy proposed
FDA IND clearance for Trace Biosciences’ nerve-specific imaging agent